UPTAKE, TRANSPORT, AND SPREAD OF PRIONS
朊病毒的摄取、运输和传播
基本信息
- 批准号:7894842
- 负责人:
- 金额:$ 40.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-15 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntibodiesApplications GrantsAreaAstrocytesAxonAxonal TransportBiological AssayBloodBovine Spongiform EncephalopathyBrainCattleCellsCellular biologyChimeric ProteinsChronic Wasting DiseaseCreutzfeldt-Jakob SyndromeDeerDendritesDepositionDetectionEtiologyExposure toFluorescence MicroscopyFood SafetyGeneticGlycolipidsHumanImageImageryInfectionInfectious AgentKuruLabelLifeLigand BindingLightLymphoidMediatingMembrane GlycoproteinsMethodsMicroscopicMolecularMonitorMorphologic artifactsMotorMovementMusMutationNerveNerve EndingsNeuraxisNeurodegenerative DisordersNeuronsNew GuineaNucleic AcidsOralOrganOrganellesPathway interactionsPeripheralPeripheral NervesPharmaceutical PreparationsPrPPrP genePrPSc ProteinsPrion DiseasesPrionsProcessProtein IsoformsProteinsPublic HealthPurkinje CellsResearchRoleRouteScrapieSheepSiteSliceSomatotropinSourceSpinal CordStaining methodStainsTestingTherapeuticTimeTissuesTransgenic MiceTravelTribesVariantcell typedesignenhanced green fluorescent proteinextracellulargranule cellimprovedinsightinterestintestinal epitheliumnovelpreventpromoterprophylacticreceptorresearch studysciatic nerveselective expressiontraffickingtransmission processuptakewild-type PrP
项目摘要
Prion diseases are fatal neurodegenerative disorders of humans and animals. They result from conversion of PrPC, a normal membrane glycoprotein into PrPSc, a conformationally altered isoform that is infectious in the
absence of nucleic acid. Most exogenously acquired prion diseases arise by exposure to the infectious agent outside of the central nervous system (CNS). For this reason, a major focus of research in the field has been to understand how prions gain access to the CNS from the periphery, and how they spread within the spinalcord and brain.
To facilitate studies of prion trafficking, we propose to utilize PrP molecules fused to enhanced green fluorescent protein (EGFP). Such PrP-EGFP fusion proteins make it possible to analyze the cellular trafficking of PrPSc in living cells in real time, and to avoid the artifacts associated with conventional immunocytochemical
detection of PrPSc. We previously created Tg(PrP-EGFP) mice in which EGFP was inserted adjacent to the glycolipid attachment site of PrP. This form of PrP-EGFP serves a highly specific ligand that binds to and labels intracellular and extracellular deposits of PrPSc in prion-infected animals. However, this particular fusion protein is not itself converted into PrPSc-EGFP, and so is subject to several experimental limitations.
In this two-year project, we propose to design improved PrP-EFGP constructs that can be converted efficiently into PrPSc-EGFP. We will then use these fluorescent proteins to visualize the transport of PrPSc along the
axons of living neurons to determine whether this movement is an intra-axonal, motor-driven process, or occurs via a "domino mechanism" on the axolemma.
We expect that the proposed experiments will provide important insights into how prions spread along nerves,and suggest how this process can be manipulated as a therapeutic or prophylactic strategy.
朊病毒病是人类和动物的致命性神经退行性疾病。它们是由PrPC(一种正常的膜糖蛋白)转化为PrPSc(一种构象改变的同种型,
没有核酸。大多数外源性获得性朊病毒疾病是由于暴露于中枢神经系统(CNS)以外的感染因子而引起的。由于这个原因,该领域研究的一个主要焦点是了解朊病毒如何从外周进入中枢神经系统,以及它们如何在脊髓和大脑中传播。
为了促进朊病毒运输的研究,我们建议利用PrP分子融合增强型绿色荧光蛋白(EGFP)。这种PrP-EGFP融合蛋白使得能够真实的分析活细胞中PrPSc的细胞运输,并避免与常规免疫细胞化学相关的伪影
PrPSc的检测。我们先前创建了Tg(PrP-EGFP)小鼠,其中EGFP插入邻近PrP的糖脂附着位点。这种形式的PrP-EGFP作为高度特异性的配体,结合并标记朊病毒感染动物中PrPSc的细胞内和细胞外沉积物。然而,这种特定的融合蛋白本身不会转化为PrPSc-EGFP,因此受到几个实验限制。
在这个为期两年的项目中,我们建议设计改进的PrP-EFGP结构,可以有效地转化为PrPSc-EGFP。然后,我们将使用这些荧光蛋白来观察PrPSc沿着
活神经元的轴突,以确定这种运动是否是轴突内的,马达驱动的过程,或通过轴膜上的“多米诺机制”发生。
我们期望所提出的实验将提供重要的见解朊病毒如何沿沿着神经传播,并建议如何操纵这一过程作为一种治疗或预防策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A HARRIS其他文献
DAVID A HARRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A HARRIS', 18)}}的其他基金
ION CHANNEL MODULATION BY THE PRION PROTEIN: A NOVEL TOXIC MECHANISM
朊病毒蛋白对离子通道的调节:一种新的毒性机制
- 批准号:
8282857 - 财政年份:2010
- 资助金额:
$ 40.63万 - 项目类别:
ION CHANNEL MODULATION BY THE PRION PROTEIN: A NOVEL TOXIC MECHANISM
朊病毒蛋白对离子通道的调节:一种新的毒性机制
- 批准号:
8539088 - 财政年份:2010
- 资助金额:
$ 40.63万 - 项目类别:
ION CHANNEL MODULATION BY THE PRION PROTEIN: A NOVEL TOXIC MECHANISM
朊病毒蛋白对离子通道的调节:一种新的毒性机制
- 批准号:
7889117 - 财政年份:2010
- 资助金额:
$ 40.63万 - 项目类别:
ION CHANNEL MODULATION BY THE PRION PROTEIN: A NOVEL TOXIC MECHANISM
朊病毒蛋白对离子通道的调节:一种新的毒性机制
- 批准号:
8289738 - 财政年份:2010
- 资助金额:
$ 40.63万 - 项目类别:
ION CHANNEL MODULATION BY THE PRION PROTEIN: A NOVEL TOXIC MECHANISM
朊病毒蛋白对离子通道的调节:一种新的毒性机制
- 批准号:
8094244 - 财政年份:2010
- 资助金额:
$ 40.63万 - 项目类别:
ION CHANNEL MODULATION BY THE PRION PROTEIN: A NOVEL TOXIC MECHANISM
朊病毒蛋白对离子通道的调节:一种新的毒性机制
- 批准号:
8679014 - 财政年份:2010
- 资助金额:
$ 40.63万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 40.63万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 40.63万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 40.63万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 40.63万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别:














{{item.name}}会员




